Moderna Submits Covid-19 Vaccine For Emergency Approval | WHAT REALLY HAPPENED

Moderna Submits Covid-19 Vaccine For Emergency Approval

Moderna is the second pharmaceutical company to request a so-called emergency use authorization (EUA) for a COVID-19 vaccine after Pfizer filed their application earlier this month. Moderna said new data showed the vaccine was 94.1% effective in its late-stage clinical trial, just under Pfizer’s efficacy rate of 95%. The Moderna vaccine was developed in conjunction with the Trump administration’s Operation Warp Speed.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA